Back to trial details

Intake questionnaire

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Applying to Kootenai Health - Coeur d'Alene · Coeur d'Alene, Idaho

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Recurrent Lung Non-Small Cell Carcinoma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Coeur d'Alene for study visits?